These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8313596)

  • 21. Combination therapy with zidovudine and dideoxycytidine in patients with advanced human immunodeficiency virus infection. A phase I/II study.
    Meng TC; Fischl MA; Boota AM; Spector SA; Bennett D; Bassiakos Y; Lai SH; Wright B; Richman DD
    Ann Intern Med; 1992 Jan; 116(1):13-20. PubMed ID: 1345755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dideoxycytidine alone and in an alternating schedule with zidovudine in children with symptomatic human immunodeficiency virus infection.
    Pizzo PA; Butler K; Balis F; Brouwers E; Hawkins M; Eddy J; Einloth M; Falloon J; Husson R; Jarosinski P
    J Pediatr; 1990 Nov; 117(5):799-808. PubMed ID: 2172501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of the antiviral agent beta-L-3'-fluoro-2',3'-didehydro-2',3'-dideoxycytidine in rhesus monkeys.
    Asif G; Hurwitz SJ; Gumina G; Chu CK; McClure HM; Schinazi RF
    Antimicrob Agents Chemother; 2005 Feb; 49(2):560-4. PubMed ID: 15673733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pilot study of the bioavailability and pharmacokinetics of 2',3'-dideoxycytidine in patients with AIDS or AIDS-related complex.
    Gustavson LE; Fukuda EK; Rubio FA; Dunton AW
    J Acquir Immune Defic Syndr (1988); 1990; 3(1):28-31. PubMed ID: 2152803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-performance liquid chromatographic method for the analysis of 2',3'-dideoxycytidine in human plasma.
    Hawkins ME; Poplack DG; Pizzo PA; Balis FM
    J Chromatogr; 1990 Nov; 532(2):442-4. PubMed ID: 1964692
    [No Abstract]   [Full Text] [Related]  

  • 26. Zalcitabine. Clinical pharmacokinetics and efficacy.
    Devineni D; Gallo JM
    Clin Pharmacokinet; 1995 May; 28(5):351-60. PubMed ID: 7614775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of pregnancy, mode of administration and neonatal age on the pharmacokinetics of zalcitabine (2', 3'-dideoxycytidine) in the pigtailed macaque (Macaca nemestrina).
    Tuntland T; Nosbisch C; Unadkat JD
    J Antimicrob Chemother; 1997 Nov; 40(5):687-93. PubMed ID: 9421317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zalcitabine population pharmacokinetics: application of radioimmunoassay.
    Adams JM; Shelton MJ; Hewitt RG; DeRemer M; DiFrancesco R; Grasela TH; Morse GD
    Antimicrob Agents Chemother; 1998 Feb; 42(2):409-13. PubMed ID: 9527795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AIDS Clinical Trials Group: phase I/II study of combination 2',3'-dideoxycytidine and zidovudine in patients with acquired immunodeficiency syndrome (AIDS) and advanced AIDS-related complex.
    Meng TC; Fischl MA; Richman DD
    Am J Med; 1990 May; 88(5B):27S-30S. PubMed ID: 2159707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantification of dideoxycytidine in human plasma by gas chromatography/mass spectrometry.
    Rubio FR; Crews T; Garland WA; Fukuda EK
    Biomed Environ Mass Spectrom; 1988 Nov; 17(5):399-404. PubMed ID: 2850042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radioimmunoassay for quantitation of 2',3'-didehydro-3'-deoxythymidine (D4T) in human plasma.
    Zhou XJ; Chakboub H; Ferrua B; Moravek J; Guedj R; Sommadossi JP
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1472-5. PubMed ID: 8726021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of 2',3'-dideoxycytidine after high-dose administration to rats.
    Ibrahim SS; Boudinot FD
    J Pharm Sci; 1991 Jan; 80(1):36-8. PubMed ID: 1849573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality of life outcomes of combination zalcitabine-zidovudine, saquinavir-zidovudine, and saquinavir-zalcitabine-zidovudine therapy for HIV-infected adults with CD4 cell counts between 50 and 350 per cubic millimeter. PISCES (SV14604) Study Group.
    Revicki DA; Moyle G; Stellbrink HJ; Barker C
    AIDS; 1999 May; 13(7):851-8. PubMed ID: 10357386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of HIV-1 in monocyte/macrophage cultures by 2',3'-dideoxycytidine-5'-triphosphate, free and in liposomes.
    Szebeni J; Wahl SM; Betageri GV; Wahl LM; Gartner S; Popovic M; Parker RJ; Black CD; Weinstein JN
    AIDS Res Hum Retroviruses; 1990 May; 6(5):691-702. PubMed ID: 2163269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of 2',3'-dideoxycytidine in rats: application to interspecies scale-up.
    Ibrahim SS; Boudinot FD
    J Pharm Pharmacol; 1989 Dec; 41(12):829-34. PubMed ID: 2576444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of anti-HIV nucleosides in microswine.
    Swagler AR; Qian MX; Gallo JM
    J Pharm Pharmacol; 1991 Dec; 43(12):823-6. PubMed ID: 1687578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct cerebrospinal fluid delivery of an antiretroviral agent using multivesicular liposomes.
    Kim S; Scheerer S; Geyer MA; Howell SB
    J Infect Dis; 1990 Sep; 162(3):750-2. PubMed ID: 2167343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and anti-HIV-1 activity of 2'-"up"-fluoro analogues of active anti-AIDS nucleosides 3'-azido-3'-deoxythymidine (AZT) and 2',3'-dideoxycytidine (DDC).
    Watanabe KA; Harada K; Zeidler J; Matulic-Adamic J; Takahashi K; Ren WY; Cheng LC; Fox JJ; Chou TC; Zhu QY
    J Med Chem; 1990 Aug; 33(8):2145-50. PubMed ID: 1695683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zalcitabine compared with zidovudine in patients with advanced HIV-1 infection who received previous zidovudine therapy.
    Fischl MA; Olson RM; Follansbee SE; Lalezari JP; Henry DH; Frame PT; Remick SC; Salgo MP; Lin AH; Nauss-Karol C; Lieberman J; Soo W
    Ann Intern Med; 1993 May; 118(10):762-9. PubMed ID: 8097082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radioimmunoassay for Retrovir, an anti-human immunodeficiency virus drug.
    Quinn RP; Orban B; Tadepalli S
    J Immunoassay; 1989; 10(2-3):177-89. PubMed ID: 2745717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.